|Articles|February 12, 2021
- Applied Clinical Trials-02-01-2021
- Volume 30
- Issue 1/2
Applied Clinical Trials, January/February 2021 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials January/February 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 5 years ago
Impact of COVID-19 on Phase I Clinical Activitiesalmost 5 years ago
Diversity in Clinical Trials Gains Ground Amidst COVIDalmost 5 years ago
Biden Pandemic Plan Highlights R&D Supportalmost 5 years ago
New Alliance Seeks to Bring Increased Accessibility to Trialsalmost 5 years ago
Improving Drug Development for Rare Patients Post-COVIDalmost 5 years ago
2021 Promises for Clinical Trialsalmost 5 years ago
Sharpening the Focus on Patient-Centricity as Pandemic Continuesalmost 5 years ago
News Notes (January & February)almost 5 years ago
EMA’s Cooke Reviews European Cancer Prospectsalmost 5 years ago
Characterizing Clinical Data Management Challenges and Their ImpactNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
Controlled Clinical Trials in Sub-Saharan Africa: A Winning Value Proposition
3
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
4
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
5

